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Miura and colleagues report a timely and significant systematic review and 
network meta-analysis of maintenance treatments for bipolar disorder. 1 They 
usefully differentiate the effects of medications on manic/mixed episodes and 
depressive episodes. 
 
What seems quite striking is how well these differences in maintenance efficacy 
match those described for the same agents in the treatment of acute episodes, 
whether manic or depressive. Simply plotting the best estimates of effect versus 
placebo on relapse prevention against response rates for acute episodes 
reported in other network meta-analyses 2,3 (Figure) reveals very substantial 
correlation for manic/mixed episodes (r -.91, p .01) and a similar trend for 
depressive episodes (r -.79, p .06). 
 
This concordance between acute and maintenance efficacy provides further 
support for the case that these analyses reveal true differences between agents 
rather than being driven by methodological artifact, and may have implications 
for the design of future mechanistic studies. 
  
 Figure. Relative efficacy of active treatments versus placebo for bipolar disorder. 
Response rates for acute episodes versus relative risk of relapse with 95% 
Confidence Intervals for manic/mixed episodes (upper panel) and depressive 
episodes (lower panel). Best fit linear regression indicated with dotted line. 
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